Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paolo Mora is active.

Publication


Featured researches published by Paolo Mora.


Retina-the Journal of Retinal and Vitreous Diseases | 2005

Indocyanine green angiography anomalies in ocular syphilis.

Paolo Mora; FranÇois-xavier Borruat; Yan Guex-Crosier

Objective: To report indocyanine green (ICG) angiography anomalies in ocular syphilis. Design: A noncomparative, interventional case series. Participants: Eight patients (16 eyes) affected by ocular syphilis. Methods: All patients presenting with a diagnosis of active ocular syphilis between January 1994 and December 2001 were evaluated by a standard fluorescein and ICG angiography protocol. ICG angiography was repeated after completion of systemic antitreponemal and antiinflammatory treatment. Results: ICG angiography anomalies were detected in 12 (75%) of 16 eyes. Two types of anomalies were observed: late-phase scattered hyperfluorescent spots (11 eyes) and persistent staining of retinal vessels (1 eye). Of these 12 eyes, 4 had no alteration by concomitant fluorescein angiography. When ICG angiography was repeated (5 ± 1 weeks after the beginning of treatment), ICG angiography anomalies disappeared. Conclusions: ICG angiography may be a valuable tool in the assessment of patients with active ocular syphilis. Retinal and choroidal vascular anomalies can be determined that would otherwise go undetected by funduscopy and/or fluorescein angiography. It can also be useful in monitoring antitreponemal therapy.


Current Eye Research | 2005

Trans-scleral diffusion of triamcinolone acetonide

Paolo Mora; Simone Eperon; Olivia Felt-Baeyens; Robert Gurny; Serge Sagodira; Pascal Breton; Yan Guex-Crosier

Purpose: To assess ex vivo human scleral permeability to triamcinolone acetonide (TA). Methods: The experiments were carried out using scleral samples and a Franz-type vertical diffusion cell. A suspension containing TA was prepared and placed in the donor chamber. The concentration of TA in the receptor chamber was measured by high-performance liquid chromatography (HPLC) assay and expressed as a percentage relative to TA concentration dissolved in the donor chamber. Control experiments using a commercial TA suspension were performed. Results: TA (±SEM) dissolved in the donor suspension was 10.69 ± 1.28 μg/ml. The diffusion rate of TA varied from 30% after 1 day to 72% after 4 days, after which equilibrium was reached. The human scleral permeability coefficient (Ps ± SEM) was 1.47± 0.17× 10− 5 cm/s. Conclusions: TA crossed human sclera. The mean amount of drug retained in the sclera increased with time, 4 days being necessary to equilibrate the unidirectional flux. The TA permeability coefficient was comparable to that of other corticosteroids.


Journal of Ophthalmology | 2016

Comparison of Surgical Outcomes between Canaloplasty and Schlemm’s Canal Scaffold at 24 Months’ Follow-Up

Stefano A. Gandolfi; Nicola Ungaro; Stella Ghirardini; Maria Grazia Tardini; Paolo Mora

The results of canaloplasty (CP) and Hydrus Microstent (HM) implantation were retrospectively compared at 24 months follow-up in a cohort of subjects referred to our Institution for uncontrolled IOP in primary or secondary (e.g., pseudoexfoliative and pigmentary) open-angle glaucoma. The outcome was labelled as “complete” success, “qualified” success, or “failure” if, two years after surgery, the eyes operated on needed “no” hypotensive medications, “some” hypotensive medications, or further glaucoma surgery to attain the target IOP, respectively. Both CP and HM implant allowed significant IOP reductions, with comparable rate of clinical success and safety profile. A slightly (albeit not significant) better trend for a “complete” clinical success was observed in the CP group.


Acta Ophthalmologica | 2016

Perioperative prophylaxis to prevent recurrence following cataract surgery in uveitic patients: a two-centre, prospective, randomized trial.

Paolo Mora; Stefania Gonzales; Stella Ghirardini; Pierangela Rubino; Jelka G. Orsoni; Stefano A. Gandolfi; François Majo; Yan Guex-Crosier

To compare the postoperative risk of inflammatory relapse in two groups of uveitic patients who underwent cataract surgery: one group had perioperative topical steroids alone and the other used topical and oral steroids.


Pediatric Infectious Disease Journal | 2009

Acute retinal necrosis in primary herpes simplex virus type I infection.

Paolo Mora; Yan Guex-Crosier; Erilda Kamberi; Jelka G. Orsoni

Here we report the case of an immunocompetent 8-year-old child who developed acute retinal necrosis concomitant with a primary herpes simplex virus type I infection. Ocular inflammation changed along with the development of a specific antibody titer in the serum. This evidence suggests that the immune response of the host can significantly modulate the clinical aspect of the ocular infection.


Italian Journal of Pediatrics | 2009

Staphylococcus aureus and autoimmune uveitis reactivation in childhood: a possible correlation?

Paolo Mora; Erilda Kamberi; Francesca Manzotti; Laura Zavota; Jelka G. Orsoni

The role of infectious agents in autoimmune diseases has been the subject of several studies and is still under investigation. Here a paediatric case series of autoimmune uveitis is reported. An exacerbation of the ocular inflammation occurred in concomitance with nasal colonisation by Staphylococcus aureus.


Journal of Ophthalmology | 2016

Altered Brain Glucose Consumption in Cogan’s Syndrome

Paolo Mora; Livia Ruffini; Caterina Ghetti; Stella Ghirardini; Maura Scarlattei; Giorgio Baldari; Carla Cidda; Pierangela Rubino; Stefano A. Gandolfi; Jelka G. Orsoni

Purpose. Prospective, controlled cohort study to investigate possible alterations in brain glucose metabolism (CMRglc) in patients with Cogans syndrome (CS). Patients and Methods. Functional mapping of the CMRglc was obtained by quantitative molecular imaging positron emission tomography, combined with computed tomography (FDG-PET/CT). The patients were divided into three clinical groups: typical CS; atypical CS (ACS); autoimmune inner ear disease (AIED). The unmatched control group (CG) consisted of subjects requiring FDG-PET/CT for an extracranial pathology. Statistical mapping searched areas of significant glucose hypometabolism in all the affected patients (DG) and in each clinical subgroup. The results were compared with those of the CG. Results. 44 patients were enrolled (DG) and assigned to the three study groups: 8 patients to the CS group; 21 patients to the ACS group; and 15 to the AIED group. Sixteen subjects formed the CG group. Areas of significant brain glucose hypometabolism were identified in all the study groups, with the largest number and extension in the DG and CS. Conclusions. This study revealed areas of significantly altered CMRglc in patients with CS (any subform) without neurologic complains and normal conventional neuroimaging. Our results suggest that FDG-PET/CT may represent a very useful tool for the global assessment of patients with Cogans syndrome.


Case reports in ophthalmological medicine | 2015

Anterior Segment Findings in Vitamin A Deficiency: A Case Series

Pierangela Rubino; Paolo Mora; Nicola Ungaro; Stefano A. Gandolfi; Jelka G. Orsoni

Vitamin A deficiency is a rare but vision threatening disorder in the developed world, which can lead to blindness for severe keratomalacia with cornea scarring and perforation or night blindness due to impaired dark adaptation. Conversely, the disease is quite common in developing countries, as a consequence of chronic malnutrition. The correct diagnosis and therapy with prompt vitamin A supplementation avoid blindness. We report a series of 3 local cases with different age and causes for vitamin A deficiency. The diagnostic workup, therapy, and prognosis are discussed.


International Journal of Pharmaceutics | 2006

Biodegradable scleral implants as new triamcinolone acetonide delivery systems

O. Felt-Baeyens; Simone Eperon; Paolo Mora; D. Limal; Serge Sagodira; Pascal Breton; B. Simonazzi; Leila Bossy-Nobs; Yan Guex-Crosier; Robert Gurny


Klinische Monatsblatter Fur Augenheilkunde | 2002

Endophtalmies d'origine fongique: prise en charge et traitement (etude sur 9 ans)

Paolo Mora; Etienne H. Bovey; Yan Guex-Crosier

Collaboration


Dive into the Paolo Mora's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge